Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005819-10Phase 4Terminated
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium bromide plus salbutamol with Salbutamol alone (2 arms). Primary endpoint: MUC5AC response. Started Oct 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005819-10.